➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
AstraZeneca
Merck
Medtronic
Boehringer Ingelheim

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Patent: 5,616,490

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,616,490
Title: Ribozymes targeted to TNF-.alpha. RNA
Abstract:An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of an inflammatory disease.
Inventor(s): Sullivan; Sean M. (Boulder, CO), Draper; Kenneth G. (Boulder, CO)
Assignee: Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Application Number:08/434,503
Patent Claims:see list of patent claims

Details for Patent 5,616,490

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ⤷  Try it Free Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-04-01 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ⤷  Try it Free Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-04-01 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ⤷  Try it Free Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-04-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 5,616,490

Country Patent Number Estimated Expiration
United States of America 2001006801 ⤷  Try it Free
United States of America 2002013458 ⤷  Try it Free
United States of America 2002082225 ⤷  Try it Free
United States of America 2002192685 ⤷  Try it Free
United States of America 2002193579 ⤷  Try it Free
United States of America 2002197684 ⤷  Try it Free
United States of America 2003003469 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Merck
Boehringer Ingelheim
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.